Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Health - May, 2006
51 articles
- Facing 85 Years, Former Impath Pres. Gets Less Than 4
- Quigley Claimants Win Right To Probe Insurance Pacts
- Boston Scientific Scores Big Win In Patent Dispute
- SeraCare Equity Holders Denied Official Committee
- WHO To Probe Global Drug Patent System
- Senator Proposes Compulsory Patent Licensing Bill
- SEC Probe Nets Another Suspect In Connetics Case
- Private Class Actions In Canada Are On The Rise
- Suros Settles With SenoRx Over Breast Biopsy Patent
- Drug Cos. Nervously Eye High Court In Landmark Case
- High Court Ruling In LabCorp Looms
- Three Execs Nabbed In Alleged HIV Testing Sham
- Pension Funds Sue UnitedHealth Over Options Backdating
- Teva Unit Takes Aim At Lilly In Chemo Patent Battle
- Shire Opens New Front In Carbatrol Litigation
- UnitedHealth Accused Of Conspiracy Over Medicare
- SeraCare Objects To Call For Equity Committee
- Chiron Dealt Blow Over Cystic Fibrosis Treatment
- Federal Circuit Reverses Ruling In Tyco Unit Suit
- Judge Tosses Shareholder Suit Over Vioxx
- Bio-Rad's License Claims False: DuPont
- UnitedHealth Faces Class Action For Options Backdating
- Cephalon Sued For Delaying Generic Competition
- Cops, Firefighters Hit Bausch & Lomb With Securities Suit
- Judge Upholds Verdicts In Stent Disputes
- Settlement Reached In Patent Dispute Over Enzyme Blends
- Court Favors Cardium In Gene Therapy Patent Dispute
- Merck Revives Spat With Teva Over Fosamax
- Barr And Eli Lilly Head Back To Court Over Prozac
- SEC Probes Backdating At UnitedHealth
- Scientists Appeal Decision In Eli Lilly Patent Suit
- Antitrust Class Action Over Cipro Reinstated
- FTC Probes King Pharmaceuticals In Antitrust Inquiry
- OCA Reorganization Plan Spawns Objections
- ITC To Investigate Roche At Amgen's Behest
- E.U. Court Tightens Rules For Protecting Drug Patents
- GlaxoSmithKline To Pay $14M In Paxil Antitrust Case
- Superpatents Spark Debate Over IP Issues
- SEC Wins Settlement From "Natural Healing" Co.
- Aventis Files Patent Suit Over Generic Allergy Drug
- U.S. Trustee Sick Over Curative Health's Proposed Plan
- Jury Awards Ariad $65.2M In Lilly Patent Feud
- Boston Scientific And Angiotech Win Stent Suit
- Varian Settles With Resonant Over Radiotherapy Patent
- Schwarz, Par Go Head To Head Over Anxiety Drug
- FTC Issues Second Request To Watson, Andrx
- USPTO Office Action Rejects Claims Of Umbilical-Cord Patents
- Malpractice Claimants Get Voice In St. Vincent Case
- Roche Sues Ranbaxy Over Generic Antiviral Drug
- New Scrushy Trial Opens Over Alleged Bribery
- Court Grants Teva-Ivax Bid For Zocor Exclusivity